Abstract
Ten patients with AIDS were enrolled in a phase I/II protocol of recombinant CD4-IgG (rCD4-IgG) treatment. Patients’ peripheral blood leukocytes (PBL) were tested before, during, and after therapy with rCD4-IgG for T helper (TH) cell function assessed by antigen- and mitogen- stimulated proliferation and interleukin-2 production in response to influenza A virus, allogeneic PBL (alloantigens), and phytohemagglutinin. Although clinical benefit was not evident, rCD4-lgG treatment was associated with rapid and potent improved TH cell function for two of three stimuli tested in 90% of the patients. These data are complemented by an in vitro experimental model that demonstrates the opposing immunologic effects ofrgp120 and rCD4-lgG on TH cell function of PBL from uninfected individuals. Thus, restoration of TH cell function by rCD4-lgG in the absence ofincreased CD4 cell counts could be due to removal ofan immunosuppressive factor, possibly gp120. These findings suggest that rCD4-lgG can induce partial restoration of immune function in AIDS patients, even in the absence of apparent short-term clinical benefit.
Original language | English (US) |
---|---|
Pages (from-to) | 1012-1016 |
Number of pages | 5 |
Journal | Journal of Infectious Diseases |
Volume | 168 |
Issue number | 4 |
DOIs | |
State | Published - Oct 1993 |
Externally published | Yes |
ASJC Scopus subject areas
- Immunology and Allergy
- Infectious Diseases